Clinical Trial Update: BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial comparing BREMEN Eye Drops to Combigan for ocular hypertension and primary open-angle glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• BREMEN Eye Drops
• Combigan (brimonidine tartrate and timolol maleate)

Snippet

Sponsor: EMS | Conditions: Ocular Hypertension, Primary Open-angle Glaucoma | Phase 3 | Status: COMPLETED